Overview

Efficacy and Safety of S 47445 Versus Placebo as Adjunctive Treatment in Depressed Patients Not Fully Recovered From Depressive Symptoms With a Current Antidepressant Treatment

Status:
Completed

Trial end date:
2017-04-01

Target enrollment:

Participant gender:

Summary

The purpose of this study is to assess the efficacy and safety of S47445 versus placebo as adjunctive treatment of Major Depressive Disorder in patients with an inadequate response to antidepressant therapy.

Phase:

Phase 2

Details

Lead Sponsor:

Institut de Recherches Internationales Servier
Servier

Collaborator:

ADIR Association

Treatments:

Antidepressive Agents
Serotonin Uptake Inhibitors